Prof. Dr. Özge Gümüşay
Medical Oncology
About Özge Gümüşay
Prof. Özge Gümüşay is a professor of clinical oncology at Acibadem University Faculty of Medicine. She was appointed professor in 2023 and has been affiliated with Acibadem Health Group since 2022, where she contributes to patient care, multidisciplinary collaboration, and medical education.
She is a member of the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO), and the Turkish Society of Medical Oncology (TTOD). Her work combines clinical practice, teaching, and research, with an emphasis on evidence-based care, ongoing professional development, and participation in national and international oncology networks.
Education
- 2023 Acibadem University Faculty of Medicine / Professor
- 2022 Acibadem University Faculty of Medicine/ Associate Professor
- 2017 Gaziosmanpaşa University Faculty of Medicine/ Associate Professor
- 2014 Gazi University Faculty of Medicine Medical Oncology
- 2010 Gazi University Faculty of Medicine Internal Medicine
- 2005 Hacettepe University Faculty of Medicine
Experience
- 2022 Acibadem Health Group
- 2021 Stanford University Comprehensive Cancer Center, Palo Alto, California, (Visiting Observer)
- 2019 – 2021 UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, (Breast Cancer Oncology)
- 2017 – 2019 Gaziosmanpaşa University Faculty of Medicine, Medical Oncology Specialist, Associate Professor
- 2014 – 2017 Gaziosmanpaşa University Faculty of Medicine, Medical Oncology Specialist, Assistant Professor
- 2010 – 2014 Gazi University Faculty of Medicine, Medical Oncology Subspecialty Research Assistant
- 2006 – 2010 Gazi University Faculty of Medicine, Internal Medicine Research Assistant
Professional Memberships
- American Society of Clinical Oncology (ASCO)
- The European Society of Medical Oncology (ESMO)
- Turkish Society of Medical Oncology (TTOD)
Selected Publications
- CDK4/6 inhibitors: Mechanisms of resistance and potential biomarkers of responsiveness in breast cancer Future Oncology, 2022 Mar;18(9):1143-1157. Cetin B, Wabl CA, Gumusay O.
- Immunotherapy Toxicity: identification and management Breast Cancer Res Treat 2022 Feb;192(1):1-17. Gumusay O, Callan J, Rugo HS.
- Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy. Front. Oncol., March 15, 2022. (share first authorship) Magbanua MJ, Gumusay O, Kurzrock R, vant Veer LJ, Rugo HS.
- The role of percutaneous vertebral augmentation in patients with metastatic breast cancer: Literature review including report of two cases Breast. 2022 Apr 2;63:149-156. Gumusay O, Huppert LA, Behr SC, Rugo HS.
- Emerging treatment strategies for metastatic triple-negative breast cancer. Therapeutic Advances in Medical Oncology. January 2022. Huppert LA, Gumusay O, Rugo HS.
- Trials of Immunotherapy in Triple Negative Breast Cancer. Curr Breast Cancer Rep 13, 171185 (2021). Gumusay O, Wabl, CA, Rugo HS.
- Pembrolizumab for Early Triple-Negative Breast Cancer. N Engl J Med 2020 Jun 25;382(26): e108. Cetin B, Gumusay O.
- Strategic Combinations to Prevent and Overcome Resistance to Targeted Therapies in Oncology. Am Soc Clin Oncol Educ Book. 2020 May;40:e292-e308. Gumusay O, Vitiello PP, Wabl C, Corcoran RB, Bardelli A, Rugo HS.
- Factors Influencing Chemotherapy Goal Perception in Newly Diagnosed Cancer Patients J Cancer Educ. 2016 Jun;31(2):308-13. Gumusay O, Cetin B, Benekli M, Gurcan G, Ilhan MN, Bostankolu B, Ozet A, Uner A, Coskun U, Buyukberber S.
- Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites Japanese Journal of Clinical Oncology. 2015 May; 45(5), 416-421. Gumusay O, Benekli M, Ekinci O, Baykara M, Ozet A, Coskun U, Demirci U, Uner A, Dursun A, Atak EY, Buyukberber S.
Schedule your appointment with Prof. Dr. Özge Gümüşay
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
